Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 05 Nov 2024

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

in Vaccines and Molecular Therapeutics

Zhuwei Liang
Chao Zhang
Xiaoyu Liu
Kaiyue Yang
Zhile Xiong
Bingshao Liang
Jialiang Mai
Xiaojun Xiao
Jie Liu
Pingchang Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428079

1,069 views

Original Research

Published on 04 Nov 2024

A dual-purpose humanized mouse model for testing antiviral strategies against both SIV and HIV

in Vaccines and Molecular Therapeutics

Ella Barnett
Snehal Kaginkar
Kimberly Schmitt
Leila Remling-Mulder
Ramesh Akkina

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491481

1,007 views

Systematic Review

Published on 01 Nov 2024

COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis

in Vaccines and Molecular Therapeutics

Ariela Hoxha
Giovanni Striani
Marco Lovisotto
Paolo Simioni
Andrea Doria
Roberta Ramonda

Frontiers in Immunology

doi 10.3389/fimmu.2024.1503895

1,303 views

Original Research

Published on 30 Oct 2024

Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against S. Paratyphi A in human samples

in Vaccines and Molecular Therapeutics

Martina Carducci
Luisa Massai
Elisa Lari
Bianca Semplici
Silvia Grappi
Noshi Maria
Elizabeth Jones
Valentino Conti
Pietro Piu
Francesco Berlanda Scorza

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443137

777 views

Review

Published on 29 Oct 2024

Mycobacterium w - a promising immunotherapeutic intervention for diseases

in Vaccines and Molecular Therapeutics

Kirsten Stefan
Ryan Gordon
Annah Rolig
Alexander Honkala
Dhanir Tailor
Lara E. Davis
Rajiv I. Modi
Manjul Joshipura
Bakulesh Khamar
Sanjay V. Malhotra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450118

1,277 views

Original Research

Published on 16 Oct 2024

Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera

in Vaccines and Molecular Therapeutics

Martina Carducci
Luisa Massai
Elisa Lari
Bianca Semplici
Maria Grazia Aruta
Daniele De Simone
Pietro Piu
Emanuele Montomoli
Francesco Berlanda Scorza
Silvia Grappi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466869

759 views

Original Research

Published on 14 Oct 2024

Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role

in Vaccines and Molecular Therapeutics

Shawkat Alam
Venkatesh Kumaresan
Rajesh Palanisamy
Yan Zhang
Janakiram Seshu
Na Xiong
Guoquan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427822

825 views

Original Research

Published on 14 Oct 2024

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

in Vaccines and Molecular Therapeutics

Gangyuan Ma
Zeping Xu
Chinyu Li
Feng Zhou
Bobo Hu
Junwei Guo
Changwen Ke
Liqing Chen
Guilin Zhang
Hungyan Lau

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451433

1,131 views

Original Research

Published on 14 Oct 2024

Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

in Vaccines and Molecular Therapeutics

Cordelia Dunai
Claire Hetherington
Sarah A. Boardman
Jordan J. Clark
Parul Sharma
Krishanthi Subramaniam
Kukatharmini Tharmaratnam
Edward J. Needham
Robyn Williams
Yun Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440324

1,809 views

Review

Published on 11 Oct 2024

Advancements in monkeypox vaccines development: a critical review of emerging technologies

in Vaccines and Molecular Therapeutics

Igor Garcia-Atutxa
Paul Mondragon-Teran
Alejandro Huerta-Saquero
Francisca Villanueva-Flores

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456060

3,361 views

Original Research

Published on 10 Oct 2024

High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection

in Vaccines and Molecular Therapeutics

Zsolt Matula
Viktória Király
Gabriella Bekő
Márton Gönczi
András Zóka
Róbert Steinhauser
Ferenc Uher
István Vályi-Nagy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448659

1,323 views

Original Research

Published on 08 Oct 2024

The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice

in Vaccines and Molecular Therapeutics

Yaxin Di
Chenchao Zhang
Zilin Ren
Renyue Jiang
Jiafeng Tang
Songhui Yang
Ziliang Wang
Tong Yu
Tong Zhang
Ziping Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483720

1,911 views

Brief Research Report

Published on 07 Oct 2024

Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d)

in Vaccines and Molecular Therapeutics

Goh Ohji
Yohei Funakoshi
Kimikazu Yakushijin
Takaji Matsutani
Tomoki Sasaki
Takahiro Kusakabe
Sakuya Matsumoto
Taiji Koyama
Yoshiaki Nagatani
Keiji Kurata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468760

1,302 views

Systematic Review

Published on 03 Oct 2024

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

in Vaccines and Molecular Therapeutics

Alisa Kazakova
Pavel Zhelnov
Roman Sidorov
Anna Rogova
Olga Vasileva
Roman Ivanov
Vasiliy Reshetnikov
Albert Muslimov

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457327

1,897 views
2 citations

Review

Published on 03 Oct 2024

Towards personalized vaccines

in Vaccines and Molecular Therapeutics

Davide Montin
Veronica Santilli
Alessandra Beni
Giorgio Costagliola
Baldassarre Martire
Maria Felicia Mastrototaro
Giorgio Ottaviano
Caterina Rizzo
Mayla Sgrulletti
Michele Miraglia Del Giudice

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436108

1,250 views

Original Research

Published on 02 Oct 2024

M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication

in Vaccines and Molecular Therapeutics

Yibo Tang
Kaiming Tang
Yunqi Hu
Zi-Wei Ye
Wanyu Luo
Cuiting Luo
Hehe Cao
Ran Wang
Xinyu Yue
Dejian Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450114

1,682 views

Navigation group

Articles

Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling

A dual-purpose humanized mouse model for testing antiviral strategies against both SIV and HIV

COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis

Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against S. Paratyphi A in human samples

Mycobacterium w - a promising immunotherapeutic intervention for diseases

Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human sera

Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain

Advancements in monkeypox vaccines development: a critical review of emerging technologies

High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection

The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice

Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d)

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies

Towards personalized vaccines

M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication